Intuitive Surgical reports preliminary FY23 da Vinci procedures grew 22%

Full year 2023 worldwide da Vinci procedures grew approximately 22% compared with 2022. The Company expects worldwide da Vinci procedures to increase approximately 13% to 16% in 2024 as compared to 2023. During early 2023, COVID-19 resurgences in China continued to negatively impact procedure volumes; however, as infections and hospitalization started to decrease, the company saw a recovery of procedure volumes. During the remainder of 2023, Intuitive did not experience significant disruptions from COVID-19. However, COVID-19 has had in the past, and could have in the future, an adverse impact on the company’s procedure volumes. Commenting on the announcement, Intuitive CEO Gary Guthart said, “We are pleased with customer adoption of our platforms and their use during the quarter and full year. We remain focused on supporting our customers’ pursuit of the quadruple aim in acute interventions.”